Is endocan a novel potential biomarker of liver steatosis and fibrosis?
Background: Studies that evaluated endocan levels in nonalcoholic fatty liver disease (NAFLD) and liver fibrosis are scarce. We aimed to explore endocan levels in relation to different stages of liver diseases, such as NAFLD, as determined with fatty liver index (FLI) and liver fibrosis, as assessed...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Society of Medical Biochemists of Serbia, Belgrade
2020-01-01
|
| Serie: | Journal of Medical Biochemistry |
| Soggetti: | |
| Accesso online: | https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2020/1452-82582003363K.pdf |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|